Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins

Medical Mycology

Volumn 48, Issue 6, 2010, Pages 858-861

  Martos, A I ^a   Romero, A ^a   Gonzalez M T ^a   Gonzalez A ^a   Serrano, C ^a   Castro, C ^a   Peman J ^b   Canton E ^b   Martn Mazuelos, E ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Aspergillus spp.; Echinocandins; Etest; Susceptibility testing

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; MICAFUNGIN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS GLAUCUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; BROTH DILUTION; CONTROLLED STUDY; EPSILOMETER TEST; FUSARIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; ASPERGILLUS; ECHINOCANDINS; FUSARIUM; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MYCOLOGY;

ASPERGILLUS; ASPERGILLUS GLAUCUS; ASPERGILLUS NIGER; FUSARIUM;

EID: 77955888487     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693781003586943     Document Type: Article

References (16)

1. Lin S, Schranz J, Teutsch S. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-366.
2. Metcalf SC, Dockrell DH. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts. J Infect 2007; 55: 287-299.
3. Oakley KL, Moore CB, Denning DW. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp. Antimicrob Agents Chemother 1998; 42: 2726-2730.
4. Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 2000; 44: 57-62.
5. Morris MI, Vilmann M. Echinocandins in the management of invasive fungal infections, part 1. Am J Health Syst Pharm 2006; 63: 1693-1703.
6. Clinical and Laboratory Standards Institute (formerly NCCLS). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi-approved standard, 2nd edn. CLSI document M38-A2. CLSI, Wayne, PA, USA, 2008.
7. Martín-Mazuelos E, Pemán J, Valverde A, et al. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp. J Antimicrob Chemother 2003; 52: 365-370.
8. Serrano MC, Morilla D, Valverde A, et al. Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole. J Clin Microbiol 2003; 41: 5270-5272.
9. Espinel-Ingroff A. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp. and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 2006; 44: 3616-3622.
10. Guinea J, Peláez T, Recio S, et al. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium and Scedosporium species. Antimicrob Agents Chemother 2008; 52: 1396-1400.
11. Espinel-Ingroff A. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol 2003; 41: 403-409.
12. Arendrup MC, Perkhofer S, Howard SJ, et al. Establishing in vitroin vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob Agents Chemother 2008; 52: 3504-3511.
13. Verweij PE, Brandt ME. A spergillus, Fusarium and other opportunistic moniliaceous fungi. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds), Manual of Clinical Microbiology, 9th edn. Washington: ASM Press, 2007: 1802-1838.
14. Clinical and Laboratory Standards Institute (formerly NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Approved Standard, 3rd edn. CLSI document M27-A3. CLSI, Wayne, PA, USA, 2008.
15. Maida CM, Milici ME, Trovato L, et al. Evaluation of the disk diffusion method compared to the microdilution method in susceptibility testing of anidulafungin against filamentous fungi. J Clin Microbiol 2008; 46: 4071-4074.
16. Arikan S, Yurdakul P, Hascelik G. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother 2003; 47: 2640-2643.